This project involves the development of a handheld near-infrared imager as an add-on unit to commercial ultrasound systems for use in breast imaging. The device is intended to help predict and assess neoadjuvant chemotherapy response.
Neoadjuvant chemotherapy is treatment given before primary therapy, and used in the management of locally advanced breast cancers. A woman may receive neoadjuvant chemotherapy to shrink a tumor that cannot be surgically removed in its current stage.
Published: September 3, 2014